CXCR4 Antagonist AMD3100 Accelerates Impaired Wound Healing in Diabetic Mice

The antagonism of CXC-chemokine receptor 4 (CXCR4) with AMD3100 improves cardiac performance after myocardial infarction by augmenting the recruitment of endothelial progenitor cells (EPCs) from the bone marrow to the regenerating vasculature. We investigated whether AMD3100 may accelerate diabetes-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Nishimura, Yukihide, Ii, Masaaki, Qin, Gangjian, Hamada, Hiromichi, Asai, Jun, Takenaka, Hideya, Sekiguchi, Haruki, Renault, Marie-Ange, Jujo, Kentaro, Katoh, Norito, Kishimoto, Saburo, Ito, Aiko, Kamide, Christine, Kenny, John, Millay, Meredith, Misener, Sol, Thorne, Tina, Losordo, Douglas W.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2011
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3276738/
https://ncbi.nlm.nih.gov/pubmed/22048734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jid.2011.356
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge